← Back to Search

Erector Spinae Block for Post-Surgery Pain in Lung Cancer

Phase 4
Recruiting
Research Sponsored by George Washington University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
pulmonary resection
18<age<90
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 24 hours postoperatively
Awards & highlights

Study Summary

This trial will test if shots of painkiller into the spine can help reduce post-surgery pain and the amount of opioids needed for patients having lung surgery.

Who is the study for?
This trial is for adults aged between 18 and 90 who are scheduled to have lung surgery (pulmonary resection). It's not suitable for those needing emergency surgery, procedures like decortication or pleurodesis, people allergic to local anesthetics, or if there are complications during surgery such as heavy bleeding.Check my eligibility
What is being tested?
The study is testing whether erector spinae injections with a continuous infusion of local anesthetic can reduce pain and the need for opioid painkillers after lung surgery. The focus is on improving postoperative recovery.See study design
What are the potential side effects?
While specific side effects aren't listed, common ones from similar procedures may include temporary back discomfort at the injection site, potential nerve damage risks, and typical anesthesia-related reactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had surgery to remove part of my lung.
Select...
I am between 18 and 90 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 24 hours postoperatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 24 hours postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain
Outcome Measure - Pain Score and Pain Medications (24 hours)
Outcome Measure - Pain Score and Pain Medications (6 hours)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Standard of Care + ESB ThoracicExperimental Treatment1 Intervention
Patients randomized to this group will receive an erector spinae block in addition to the standard of care treatment
Group II: Standard of CareActive Control1 Intervention
Patients randomized to this group will receive standard of care treatment and NO erector spinae block

Find a Location

Who is running the clinical trial?

George Washington UniversityLead Sponsor
243 Previous Clinical Trials
453,629 Total Patients Enrolled

Media Library

ESB Thoracic Clinical Trial Eligibility Overview. Trial Name: NCT05521789 — Phase 4
Lung Cancer Research Study Groups: Standard of Care + ESB Thoracic, Standard of Care
Lung Cancer Clinical Trial 2023: ESB Thoracic Highlights & Side Effects. Trial Name: NCT05521789 — Phase 4
ESB Thoracic 2023 Treatment Timeline for Medical Study. Trial Name: NCT05521789 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor open for enrollment?

"Correct. The clinicaltrials.gov platform has the latest information, indicating that this experiment began on July 22nd 2022 and is actively seeking participants. Seventy individuals are needed from one medical centre to take part in the trial."

Answered by AI

Has the ESB Thoracic device achieved clearance from the Food and Drug Administration?

"Based on our team's evaluation, ESB Thoracic has been judged to possess a relatively high safety rating of 3 due to its status as an approved phase 4 trial."

Answered by AI

Am I eligible to participate in this research endeavor?

"The criteria for entry into this clinical trial includes the presence of thoracic neoplasms and an age range between 18-90 years old. A total of 70 patients are needed to complete the study."

Answered by AI

Is this research project open to people below the age of eighty?

"The requirements for this research trial are that participants must be between 18 and 90 years old. In contrast, there are 337 clinical trials available to younger patients and 3671 opportunities for individuals above 65."

Answered by AI

What is the enrollment rate for this clinical trial?

"Indeed, clinicaltrials.gov states that this research endeavour is actively enlisting participants. The original posting date of the trial was July 22nd 2022 and the last changes were made on August 29th 2022. A total of 70 people are being selected to take part in this study from one single site."

Answered by AI
~9 spots leftby Jul 2024